COLL
Collegium Pharmaceutical, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.68
−0.08%Margins
Gross margin
60.0%
EBITDA margin
72.6%
EBIT margin
19.6%
Net margin
5.9%
FCF margin
40.6%
15.4%
Return on equity
2.2%
Return on assets
13.6%
Return on invested capital
0.43x
Asset turnover
$329.9M
Cash from operations
$4.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026